Sonnet BioTherapeutics Holdings Inc. Shares Are Up -73.26% Since The Beginning Of The Year – Marketing Sentinel
Home  »  Business   »  Sonnet BioTherapeutics Holdings Inc. Shares Are Up...

Sonnet BioTherapeutics Holdings Inc. Shares Are Up -73.26% Since The Beginning Of The Year

Sonnet BioTherapeutics Holdings Inc. (NASDAQ:SONN) has a beta value of 0.66 and has seen 6.02 million shares traded in the last trading session. The company, currently valued at $37.88M, closed the last trade at $0.66 per share which meant it gained $0.01 on the day or 1.00% during that session. The SONN stock price is -416.67% off its 52-week high price of $3.41 and 16.67% above the 52-week low of $0.55. If we look at the company’s 10-day average daily trading volume, we find that it stood at 27.57 million shares traded. The 3-month trading volume is 8.03 million shares.

The consensus among analysts is that Sonnet BioTherapeutics Holdings Inc. (SONN) is a Buy stock at the moment, with a recommendation rating of 2.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 1 have rated it as a Hold, with 1 advising it as a Buy. 0 have rated the stock as Underweight.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored

Sonnet BioTherapeutics Holdings Inc. (NASDAQ:SONN) trade information

Sporting 1.00% in the green in last session, the stock has traded in the green over the last five days, with the highest price hit on Friday, 09/03/21 when the SONN stock price touched $0.66 or saw a rise of 17.5%. Year-to-date, Sonnet BioTherapeutics Holdings Inc. shares have moved -70.51%, while the 5-day performance has seen it change 13.91%. Over the past 30 days, the shares of Sonnet BioTherapeutics Holdings Inc. (NASDAQ:SONN) have changed -37.95%. Short interest in the company has seen 0.53 million shares shorted with days to cover at 0.3.

Wall Street analysts have a consensus price target for the stock at $8.00, which means that the shares’ value could jump 91.75% from current levels. The projected low price target is $8.00 while the price target rests at a high of $8.00. In that case, then, we find that the current price level is -1112.12% off the targeted high while a plunge would see the stock gain -1112.12% from current levels.

Sonnet BioTherapeutics Holdings Inc. (SONN) estimates and forecasts

The company’s shares have lost -68.38% over the past 6 months.

If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 45.70% over the past 5 years.

SONN Dividends

Sonnet BioTherapeutics Holdings Inc. is expected to release its next earnings report between August 12 and August 16 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.

Sonnet BioTherapeutics Holdings Inc. (NASDAQ:SONN)’s Major holders

Insiders own 8.80% of the company shares, while shares held by institutions stand at 3.44% with a share float percentage of 3.77%. Investors are also buoyed by the number of investors in a company, with Sonnet BioTherapeutics Holdings Inc. having a total of 24 institutions that hold shares in the company. The top two institutional holders are Blackrock Inc. with over 0.26 million shares worth more than $0.58 million. As of Mar 30, 2021, Blackrock Inc. held 1.21% of shares outstanding.

The other major institutional holder is Vanguard Group, Inc. (The), with the holding of over 0.14 million shares as of Mar 30, 2021. The firm’s total holdings are worth over $0.31 million and represent 0.64% of shares outstanding.

>> 7 Top Picks for the Post-Pandemic Economy <<

Also the top two Mutual Funds that are holding company’s shares are Vanguard Total Stock Market Index Fund and iShares Micro Cap ETF. As of Mar 30, 2021, the former fund manager holds about 0.64% shares in the company for having 0.14 million shares of worth $0.31 million while later fund manager owns 45126.0 shares of worth $0.11 million as of Apr 29, 2021, which makes it owner of about 0.21% of company’s outstanding stock.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Leave a Comment

Your email address will not be published. Required fields are marked *

On Key

Related Posts

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

173226

100% free. stop anytime no spam

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

173226

100% free. stop anytime no spam